Theravance Biopharma — Hyde Park, New York

Theravance Biopharma is a clinical research site located in Hyde Park, New York, United States 11040.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Theravance Biopharma has participated in 1 clinical trials.

Therapeutic areas: Acute Lung Injury (ALI) Associated With COVID-19, Lung Inflammation Associated With COVID-19.

Sponsors: Theravance Biopharma.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Theravance Biopharma?

Theravance Biopharma has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Theravance Biopharma conducted?

Theravance Biopharma has 1 clinical trials on record. Their work covers Acute Lung Injury (ALI) Associated With COVID-19, Lung Inflammation Associated With COVID-19.

Is Theravance Biopharma accredited by Crixeo Health?

Theravance Biopharma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Theravance Biopharma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.